Constellation Pharmaceuticals' Grant

Constellation Pharmaceuticals raised a round of funding on January 06, 2011. Investors include Multiple Myeloma Research Foundation.

Constellation Pharmaceuticals (NASDAQ: CNST) is a biopharmaceutical company dedicated to the development of therapeutics in the emerging field of Epigenetics, a new field of science involving selectiv…

Articles about Constellation Pharmaceuticals' Grant: